Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raffaella Origa

Showing results (41-50 of 93) with videos related to

Pageof 10
Sort By:
American Journal of Hematology|April 22, 2026
The Emerging Role of Liver Stiffness Measurement in Transfusion Dependent ThalassemiaBarbara Gianesin, Giovanni Battista Ferrero, Filomena Longo, et al.
Blood|October 15, 2016
Current growth patterns in children and adolescents with thalassemia majorRaffaella Origa, Fabrice Danjou, Valeria Orecchia, et al.
Hemasphere|May 10, 2021
Selecting β-thalassemia Patients for Gene Therapy: A Decision-making AlgorithmDonatella Baronciani, Maddalena Casale, Lucia De Franceschi, et al.
Recenti Progressi in Medicina|August 8, 2022
[The Management of Endocrine Complications in Patients with Haemoglobinopathies: Good Clinical Practice of the Italian Society of Thalassemia and Haemoglobinopathies (SITE).]Maddalena Casale, Marina Baldini, Patrizia Del Monte, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|June 21, 2018
Quality of life in Sardinian patients with transfusion-dependent Thalassemia: a cross-sectional studyFrancesca Floris, Federica Comitini, GiovanBattista Leoni, et al.
Annals of Hepatology|April 13, 2015
IFNL3 polymorphisms and HCV infection in patients with beta thalassemiaRaffaella Origa, Giuseppe Marceddu, Fabrice Danjou, et al.
American Journal of Hematology|January 22, 2019
Influence of patient-reported outcomes on the treatment effect of deferasirox film-coated and dispersible tablet formulations in the ECLIPSE trial: A post hoc mediation analysisAli T Taher, Raffaella Origa, Silverio Perrotta, et al.
Journal of Clinical Medicine|April 12, 2022
Good Clinical Practice of the Italian Society of Thalassemia and Haemoglobinopathies (SITE) for the Management of Endocrine Complications in Patients with HaemoglobinopathiesMaddalena Casale, Marina Itala Baldini, Patrizia Del Monte, et al.
American Journal of Hematology|May 16, 2022
Crushed deferasirox film-coated tablets in pediatric patients with transfusional hemosiderosis: Results from a single-arm, interventional phase 4 study (MIMAS)Yasser Wali, Tamer Hassan, Pimlak Charoenkwan, et al.
British Journal of Haematology|May 23, 2024
Deferasirox film-coated tablet-associated ulcerative colitis: An emerging pattern in thalassemia patients?Andrea Piolatto, Carmen Maria Gaglioti, Nicolò Tesio, et al.
Pageof 10

Showing results (41-50 of 93) with videos related to

Sort By:
Pageof 10
American Journal of Hematology|April 22, 2026
The Emerging Role of Liver Stiffness Measurement in Transfusion Dependent ThalassemiaBarbara Gianesin, Giovanni Battista Ferrero, Filomena Longo, et al.
Blood|October 15, 2016
Current growth patterns in children and adolescents with thalassemia majorRaffaella Origa, Fabrice Danjou, Valeria Orecchia, et al.
Hemasphere|May 10, 2021
Selecting β-thalassemia Patients for Gene Therapy: A Decision-making AlgorithmDonatella Baronciani, Maddalena Casale, Lucia De Franceschi, et al.
Recenti Progressi in Medicina|August 8, 2022
[The Management of Endocrine Complications in Patients with Haemoglobinopathies: Good Clinical Practice of the Italian Society of Thalassemia and Haemoglobinopathies (SITE).]Maddalena Casale, Marina Baldini, Patrizia Del Monte, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|June 21, 2018
Quality of life in Sardinian patients with transfusion-dependent Thalassemia: a cross-sectional studyFrancesca Floris, Federica Comitini, GiovanBattista Leoni, et al.
Annals of Hepatology|April 13, 2015
IFNL3 polymorphisms and HCV infection in patients with beta thalassemiaRaffaella Origa, Giuseppe Marceddu, Fabrice Danjou, et al.
American Journal of Hematology|January 22, 2019
Influence of patient-reported outcomes on the treatment effect of deferasirox film-coated and dispersible tablet formulations in the ECLIPSE trial: A post hoc mediation analysisAli T Taher, Raffaella Origa, Silverio Perrotta, et al.
Journal of Clinical Medicine|April 12, 2022
Good Clinical Practice of the Italian Society of Thalassemia and Haemoglobinopathies (SITE) for the Management of Endocrine Complications in Patients with HaemoglobinopathiesMaddalena Casale, Marina Itala Baldini, Patrizia Del Monte, et al.
American Journal of Hematology|May 16, 2022
Crushed deferasirox film-coated tablets in pediatric patients with transfusional hemosiderosis: Results from a single-arm, interventional phase 4 study (MIMAS)Yasser Wali, Tamer Hassan, Pimlak Charoenkwan, et al.
British Journal of Haematology|May 23, 2024
Deferasirox film-coated tablet-associated ulcerative colitis: An emerging pattern in thalassemia patients?Andrea Piolatto, Carmen Maria Gaglioti, Nicolò Tesio, et al.
Pageof 10